EraGen Biosciences Gets FDA Clearance of First Herpes Simplex Virus Test

EraGen Biosciences Wednesday announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance for EraGen’s MultiCode-RTx HSV 1&2 Kit.
Earth Times